Respiratory syncytial virus infections has been the subject of sustained clinical investigation across multiple research sites.

14 total trials for this combination

Showing top 10 of 14 trials

Trials

NCT ID	Title	Status	Phase
NCT05026749	Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children	RECRUITING	PHASE3
NCT03979313	A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY)	COMPLETED	PHASE3
NCT03959488	A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children	COMPLETED	PHASE2/PHASE3
NCT02878330	A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended RSV LRTI in Healthy Preterm Infants.	COMPLETED	PHASE2
NCT02325791	Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants	COMPLETED	PHASE3
NCT02202356	A Study of ALS-008176 in Infants Hospitalized With RSV	COMPLETED	PHASE1
NCT04886596	Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above	COMPLETED	PHASE3
NCT00129766	Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children	COMPLETED	PHASE3
NCT06534892	An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study	ACTIVE_NOT_RECRUITING	PHASE3
NCT05238025	MVA-BN-RSV Vaccine Trial	TERMINATED	PHASE3

Related Pages

All Respiratory syncytial virus infections trials All trials in Columbus, United States